カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の標識ペプチド市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Labeled Peptides Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO18033）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO18033
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：91
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の標識ペプチド市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

標識ペプチド市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の標識ペプチドの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

標識ペプチド市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・(Arg)9, FAM標識、(Arg)9, TAMRA標識、その他

用途別セグメントは次のように区分されます。
・タンパク質化学、免疫学、組織化学、その他

世界の標識ペプチド市場の主要な市場プレーヤーは以下のとおりです。
・Pepscan、JPT Peptide Technologies、PEPTIDE INSTITUTE、Merck、BIOSYNTAN GmbH、LifeTein、Eurogentec

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、標識ペプチド製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な標識ペプチドメーカーの企業概要、2019年～2022年までの標識ペプチドの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な標識ペプチドメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別標識ペプチドの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの標識ペプチドの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での標識ペプチド市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および標識ペプチドの産業チェーンを掲載しています。
・第13、14、15章では、標識ペプチドの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 標識ペプチドの概要
- 種類別分析（2017年vs2021年vs2028年）：(Arg)9, FAM標識、(Arg)9, TAMRA標識、その他
- 用途別分析（2017年vs2021年vs2028年）：タンパク質化学、免疫学、組織化学、その他
- 世界の標識ペプチド市場規模・予測
- 世界の標識ペプチド生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Pepscan、JPT Peptide Technologies、PEPTIDE INSTITUTE、Merck、BIOSYNTAN GmbH、LifeTein、Eurogentec
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：(Arg)9, FAM標識、(Arg)9, TAMRA標識、その他
・用途別分析2017年-2028年：タンパク質化学、免疫学、組織化学、その他
・標識ペプチドの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・標識ペプチドのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・標識ペプチドのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・標識ペプチドの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・標識ペプチドの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Labeled Peptides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Labeled Peptides market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Protein Chemistry accounting for % of the Labeled Peptides global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While (Arg)9, FAM-labeled segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Labeled Peptides include Pepscan, JPT Peptide Technologies, PEPTIDE INSTITUTE, Merck, and BIOSYNTAN GmbH, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Labeled Peptides market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
(Arg)9, FAM-labeled
(Arg)9, TAMRA-labeled
Others
Market segment by Application can be divided into
Protein Chemistry
Immunology
Histochemistry
Others
The key market players for global Labeled Peptides market are listed below:
Pepscan
JPT Peptide Technologies
PEPTIDE INSTITUTE
Merck
BIOSYNTAN GmbH
LifeTein
Eurogentec
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Labeled Peptides product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Labeled Peptides, with price, sales, revenue and global market share of Labeled Peptides from 2019 to 2022.
Chapter 3, the Labeled Peptides competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Labeled Peptides breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Labeled Peptides market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Labeled Peptides.
Chapter 13, 14, and 15, to describe Labeled Peptides sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Labeled Peptides Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Labeled Peptides Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 (Arg)9, FAM-labeled
1.2.3 (Arg)9, TAMRA-labeled
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Labeled Peptides Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Protein Chemistry
1.3.3 Immunology
1.3.4 Histochemistry
1.3.5 Others
1.4 Global Labeled Peptides Market Size & Forecast
1.4.1 Global Labeled Peptides Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Labeled Peptides Sales in Volume (2017-2028)
1.4.3 Global Labeled Peptides Price (2017-2028)
1.5 Global Labeled Peptides Production Capacity Analysis
1.5.1 Global Labeled Peptides Total Production Capacity (2017-2028)
1.5.2 Global Labeled Peptides Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Labeled Peptides Market Drivers
1.6.2 Labeled Peptides Market Restraints
1.6.3 Labeled Peptides Trends Analysis
2 Manufacturers Profiles
2.1 Pepscan
2.1.1 Pepscan Details
2.1.2 Pepscan Major Business
2.1.3 Pepscan Labeled Peptides Product and Services
2.1.4 Pepscan Labeled Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 JPT Peptide Technologies
2.2.1 JPT Peptide Technologies Details
2.2.2 JPT Peptide Technologies Major Business
2.2.3 JPT Peptide Technologies Labeled Peptides Product and Services
2.2.4 JPT Peptide Technologies Labeled Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 PEPTIDE INSTITUTE
2.3.1 PEPTIDE INSTITUTE Details
2.3.2 PEPTIDE INSTITUTE Major Business
2.3.3 PEPTIDE INSTITUTE Labeled Peptides Product and Services
2.3.4 PEPTIDE INSTITUTE Labeled Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Labeled Peptides Product and Services
2.4.4 Merck Labeled Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 BIOSYNTAN GmbH
2.5.1 BIOSYNTAN GmbH Details
2.5.2 BIOSYNTAN GmbH Major Business
2.5.3 BIOSYNTAN GmbH Labeled Peptides Product and Services
2.5.4 BIOSYNTAN GmbH Labeled Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 LifeTein
2.6.1 LifeTein Details
2.6.2 LifeTein Major Business
2.6.3 LifeTein Labeled Peptides Product and Services
2.6.4 LifeTein Labeled Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Eurogentec
2.7.1 Eurogentec Details
2.7.2 Eurogentec Major Business
2.7.3 Eurogentec Labeled Peptides Product and Services
2.7.4 Eurogentec Labeled Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Labeled Peptides Breakdown Data by Manufacturer
3.1 Global Labeled Peptides Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Labeled Peptides Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Labeled Peptides
3.4 Market Concentration Rate
3.4.1 Top 3 Labeled Peptides Manufacturer Market Share in 2021
3.4.2 Top 6 Labeled Peptides Manufacturer Market Share in 2021
3.5 Global Labeled Peptides Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Labeled Peptides Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Labeled Peptides Market Size by Region
4.1.1 Global Labeled Peptides Sales in Volume by Region (2017-2028)
4.1.2 Global Labeled Peptides Revenue by Region (2017-2028)
4.2 North America Labeled Peptides Revenue (2017-2028)
4.3 Europe Labeled Peptides Revenue (2017-2028)
4.4 Asia-Pacific Labeled Peptides Revenue (2017-2028)
4.5 South America Labeled Peptides Revenue (2017-2028)
4.6 Middle East and Africa Labeled Peptides Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Labeled Peptides Sales in Volume by Type (2017-2028)
5.2 Global Labeled Peptides Revenue by Type (2017-2028)
5.3 Global Labeled Peptides Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Labeled Peptides Sales in Volume by Application (2017-2028)
6.2 Global Labeled Peptides Revenue by Application (2017-2028)
6.3 Global Labeled Peptides Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Labeled Peptides Sales by Type (2017-2028)
7.2 North America Labeled Peptides Sales by Application (2017-2028)
7.3 North America Labeled Peptides Market Size by Country
7.3.1 North America Labeled Peptides Sales in Volume by Country (2017-2028)
7.3.2 North America Labeled Peptides Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Labeled Peptides Sales by Type (2017-2028)
8.2 Europe Labeled Peptides Sales by Application (2017-2028)
8.3 Europe Labeled Peptides Market Size by Country
8.3.1 Europe Labeled Peptides Sales in Volume by Country (2017-2028)
8.3.2 Europe Labeled Peptides Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Labeled Peptides Sales by Type (2017-2028)
9.2 Asia-Pacific Labeled Peptides Sales by Application (2017-2028)
9.3 Asia-Pacific Labeled Peptides Market Size by Region
9.3.1 Asia-Pacific Labeled Peptides Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Labeled Peptides Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Labeled Peptides Sales by Type (2017-2028)
10.2 South America Labeled Peptides Sales by Application (2017-2028)
10.3 South America Labeled Peptides Market Size by Country
10.3.1 South America Labeled Peptides Sales in Volume by Country (2017-2028)
10.3.2 South America Labeled Peptides Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Labeled Peptides Sales by Type (2017-2028)
11.2 Middle East & Africa Labeled Peptides Sales by Application (2017-2028)
11.3 Middle East & Africa Labeled Peptides Market Size by Country
11.3.1 Middle East & Africa Labeled Peptides Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Labeled Peptides Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Labeled Peptides and Key Manufacturers
12.2 Manufacturing Costs Percentage of Labeled Peptides
12.3 Labeled Peptides Production Process
12.4 Labeled Peptides Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Labeled Peptides Typical Distributors
13.3 Labeled Peptides Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Labeled Peptides Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Labeled Peptides Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pepscan Basic Information, Manufacturing Base and Competitors
Table 4. Pepscan Major Business
Table 5. Pepscan Labeled Peptides Product and Services
Table 6. Pepscan Labeled Peptides Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. JPT Peptide Technologies Basic Information, Manufacturing Base and Competitors
Table 8. JPT Peptide Technologies Major Business
Table 9. JPT Peptide Technologies Labeled Peptides Product and Services
Table 10. JPT Peptide Technologies Labeled Peptides Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. PEPTIDE INSTITUTE Basic Information, Manufacturing Base and Competitors
Table 12. PEPTIDE INSTITUTE Major Business
Table 13. PEPTIDE INSTITUTE Labeled Peptides Product and Services
Table 14. PEPTIDE INSTITUTE Labeled Peptides Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Labeled Peptides Product and Services
Table 18. Merck Labeled Peptides Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. BIOSYNTAN GmbH Basic Information, Manufacturing Base and Competitors
Table 20. BIOSYNTAN GmbH Major Business
Table 21. BIOSYNTAN GmbH Labeled Peptides Product and Services
Table 22. BIOSYNTAN GmbH Labeled Peptides Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. LifeTein Basic Information, Manufacturing Base and Competitors
Table 24. LifeTein Major Business
Table 25. LifeTein Labeled Peptides Product and Services
Table 26. LifeTein Labeled Peptides Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Eurogentec Basic Information, Manufacturing Base and Competitors
Table 28. Eurogentec Major Business
Table 29. Eurogentec Labeled Peptides Product and Services
Table 30. Eurogentec Labeled Peptides Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Labeled Peptides Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 32. Global Labeled Peptides Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Labeled Peptides, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Labeled Peptides Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Labeled Peptides Production Site of Key Manufacturer
Table 36. Labeled Peptides New Entrant and Capacity Expansion Plans
Table 37. Labeled Peptides Mergers & Acquisitions in the Past Five Years
Table 38. Global Labeled Peptides Sales by Region (2017-2022) & (K Units)
Table 39. Global Labeled Peptides Sales by Region (2023-2028) & (K Units)
Table 40. Global Labeled Peptides Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Labeled Peptides Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Labeled Peptides Sales by Type (2017-2022) & (K Units)
Table 43. Global Labeled Peptides Sales by Type (2023-2028) & (K Units)
Table 44. Global Labeled Peptides Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Labeled Peptides Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Labeled Peptides Price by Type (2017-2022) & (US$/Unit)
Table 47. Global Labeled Peptides Price by Type (2023-2028) & (US$/Unit)
Table 48. Global Labeled Peptides Sales by Application (2017-2022) & (K Units)
Table 49. Global Labeled Peptides Sales by Application (2023-2028) & (K Units)
Table 50. Global Labeled Peptides Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Labeled Peptides Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Labeled Peptides Price by Application (2017-2022) & (US$/Unit)
Table 53. Global Labeled Peptides Price by Application (2023-2028) & (US$/Unit)
Table 54. North America Labeled Peptides Sales by Country (2017-2022) & (K Units)
Table 55. North America Labeled Peptides Sales by Country (2023-2028) & (K Units)
Table 56. North America Labeled Peptides Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Labeled Peptides Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Labeled Peptides Sales by Type (2017-2022) & (K Units)
Table 59. North America Labeled Peptides Sales by Type (2023-2028) & (K Units)
Table 60. North America Labeled Peptides Sales by Application (2017-2022) & (K Units)
Table 61. North America Labeled Peptides Sales by Application (2023-2028) & (K Units)
Table 62. Europe Labeled Peptides Sales by Country (2017-2022) & (K Units)
Table 63. Europe Labeled Peptides Sales by Country (2023-2028) & (K Units)
Table 64. Europe Labeled Peptides Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Labeled Peptides Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Labeled Peptides Sales by Type (2017-2022) & (K Units)
Table 67. Europe Labeled Peptides Sales by Type (2023-2028) & (K Units)
Table 68. Europe Labeled Peptides Sales by Application (2017-2022) & (K Units)
Table 69. Europe Labeled Peptides Sales by Application (2023-2028) & (K Units)
Table 70. Asia-Pacific Labeled Peptides Sales by Region (2017-2022) & (K Units)
Table 71. Asia-Pacific Labeled Peptides Sales by Region (2023-2028) & (K Units)
Table 72. Asia-Pacific Labeled Peptides Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Labeled Peptides Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Labeled Peptides Sales by Type (2017-2022) & (K Units)
Table 75. Asia-Pacific Labeled Peptides Sales by Type (2023-2028) & (K Units)
Table 76. Asia-Pacific Labeled Peptides Sales by Application (2017-2022) & (K Units)
Table 77. Asia-Pacific Labeled Peptides Sales by Application (2023-2028) & (K Units)
Table 78. South America Labeled Peptides Sales by Country (2017-2022) & (K Units)
Table 79. South America Labeled Peptides Sales by Country (2023-2028) & (K Units)
Table 80. South America Labeled Peptides Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Labeled Peptides Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Labeled Peptides Sales by Type (2017-2022) & (K Units)
Table 83. South America Labeled Peptides Sales by Type (2023-2028) & (K Units)
Table 84. South America Labeled Peptides Sales by Application (2017-2022) & (K Units)
Table 85. South America Labeled Peptides Sales by Application (2023-2028) & (K Units)
Table 86. Middle East & Africa Labeled Peptides Sales by Region (2017-2022) & (K Units)
Table 87. Middle East & Africa Labeled Peptides Sales by Region (2023-2028) & (K Units)
Table 88. Middle East & Africa Labeled Peptides Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Labeled Peptides Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Labeled Peptides Sales by Type (2017-2022) & (K Units)
Table 91. Middle East & Africa Labeled Peptides Sales by Type (2023-2028) & (K Units)
Table 92. Middle East & Africa Labeled Peptides Sales by Application (2017-2022) & (K Units)
Table 93. Middle East & Africa Labeled Peptides Sales by Application (2023-2028) & (K Units)
Table 94. Labeled Peptides Raw Material
Table 95. Key Manufacturers of Labeled Peptides Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Labeled Peptides Typical Distributors
Table 99. Labeled Peptides Typical Customers
List of Figures
Figure 1. Labeled Peptides Picture
Figure 2. Global Labeled Peptides Revenue Market Share by Type in 2021
Figure 3. (Arg)9, FAM-labeled
Figure 4. (Arg)9, TAMRA-labeled
Figure 5. Others
Figure 6. Global Labeled Peptides Revenue Market Share by Application in 2021
Figure 7. Protein Chemistry
Figure 8. Immunology
Figure 9. Histochemistry
Figure 10. Others
Figure 11. Global Labeled Peptides Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Labeled Peptides Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Labeled Peptides Sales (2017-2028) & (K Units)
Figure 14. Global Labeled Peptides Price (2017-2028) & (US$/Unit)
Figure 15. Global Labeled Peptides Production Capacity (2017-2028) & (K Units)
Figure 16. Global Labeled Peptides Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Labeled Peptides Market Drivers
Figure 18. Labeled Peptides Market Restraints
Figure 19. Labeled Peptides Market Trends
Figure 20. Global Labeled Peptides Sales Market Share by Manufacturer in 2021
Figure 21. Global Labeled Peptides Revenue Market Share by Manufacturer in 2021
Figure 22. Labeled Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Labeled Peptides Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Labeled Peptides Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Labeled Peptides Sales Market Share by Region (2017-2028)
Figure 26. Global Labeled Peptides Revenue Market Share by Region (2017-2028)
Figure 27. North America Labeled Peptides Revenue (2017-2028) & (USD Million)
Figure 28. Europe Labeled Peptides Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Labeled Peptides Revenue (2017-2028) & (USD Million)
Figure 30. South America Labeled Peptides Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Labeled Peptides Revenue (2017-2028) & (USD Million)
Figure 32. Global Labeled Peptides Sales Market Share by Type (2017-2028)
Figure 33. Global Labeled Peptides Revenue Market Share by Type (2017-2028)
Figure 34. Global Labeled Peptides Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Labeled Peptides Sales Market Share by Application (2017-2028)
Figure 36. Global Labeled Peptides Revenue Market Share by Application (2017-2028)
Figure 37. Global Labeled Peptides Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Labeled Peptides Sales Market Share by Type (2017-2028)
Figure 39. North America Labeled Peptides Sales Market Share by Application (2017-2028)
Figure 40. North America Labeled Peptides Sales Market Share by Country (2017-2028)
Figure 41. North America Labeled Peptides Revenue Market Share by Country (2017-2028)
Figure 42. United States Labeled Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Labeled Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Labeled Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Labeled Peptides Sales Market Share by Type (2017-2028)
Figure 46. Europe Labeled Peptides Sales Market Share by Application (2017-2028)
Figure 47. Europe Labeled Peptides Sales Market Share by Country (2017-2028)
Figure 48. Europe Labeled Peptides Revenue Market Share by Country (2017-2028)
Figure 49. Germany Labeled Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Labeled Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Labeled Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Labeled Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Labeled Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Labeled Peptides Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Labeled Peptides Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Labeled Peptides Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Labeled Peptides Revenue Market Share by Region (2017-2028)
Figure 58. China Labeled Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Labeled Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Labeled Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Labeled Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Labeled Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Labeled Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Labeled Peptides Sales Market Share by Type (2017-2028)
Figure 65. South America Labeled Peptides Sales Market Share by Application (2017-2028)
Figure 66. South America Labeled Peptides Sales Market Share by Country (2017-2028)
Figure 67. South America Labeled Peptides Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Labeled Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Labeled Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Labeled Peptides Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Labeled Peptides Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Labeled Peptides Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Labeled Peptides Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Labeled Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Labeled Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Labeled Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Labeled Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Labeled Peptides in 2021
Figure 79. Manufacturing Process Analysis of Labeled Peptides
Figure 80. Labeled Peptides Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 内因性ペプチド物質のグローバル市場展望 2023年-2029年：神経ペプチド、ホルモン、サイトカイン、ペプチドホルモン、生理活性ペプチド
  • 世界のブロッキングペプチド市場2022年：市場規模予測（～2028年）
  • ペプチドライブラリースクリーニングサービスのグローバル市場展望 2023年-2029年：固相スクリーニング、液相スクリーニング、In Vivoスクリーニング、全細胞スクリーニング、その他
  • 世界の化粧品用ペプチド合成市場2022年：市場規模予測（～2028年）
  • 世界のペプチド抗生物質無菌注射剤市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO18033 )"世界の標識ペプチド市場2022年：市場規模予測（～2028年）" (英文：Global Labeled Peptides Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。